查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1926901

低功耗行動C型臂市場：按技術、應用和最終用戶分類－2026年至2032年全球預測

Low Power Mobile C-arm Market by Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，低功耗行動 C 型臂市場價值將達到 11.9 億美元，到 2026 年將成長到 12.8 億美元，到 2032 年將達到 19.7 億美元，年複合成長率為 7.42%。

關鍵市場統計數據
基準年 2025 11.9億美元
預計年份：2026年 12.8億美元
預測年份 2032 19.7億美元
複合年成長率 (%) 7.42%

了解正在重塑現代醫療環境中低功耗行動 C 型臂應用的臨床背景、採購重點和技術預期。

本執行摘要概述了低功耗移動式C臂在現代臨床工作流程中不斷演變的角色，並重點介紹了技術進步和醫療服務模式的變革如何重塑採購和使用模式。討論首先從臨床因素入手：微創手術、床邊介入治療以及在傳統手術室外進行的手術的興起，推動了對緊湊型、低劑量成像解決方案的需求。同時，臨床醫生也在尋求能夠兼顧影像品質和移動性的系統，以支援患者快速週轉、縮短手術時間並提高患者吞吐量。

說明技術、臨床工作流程和服務模式的變革如何從根本上改變移動式 C 型臂供應商的採購標準和競爭地位

技術創新和醫療服務模式的轉變正在改變行動C臂的競爭格局。平板檢測器和先進影像處理演算法的進步正逐步縮小攜帶式和固定式成像系統之間的性能差距，使臨床醫生能夠以更小的面積和更低的電力消耗進行更複雜的介入手術。同時，電池系統和輕質材料的進步使得手術過程中的重新定位更加快速流暢，從而在門診、床邊和混合手術環境中催生了新的工作流程。

評估美國新關稅如何影響移動式C臂相關人員的採購選擇、總到岸成本和採購風險管理

近期關稅調整對診斷成像設備的製造商、經銷商和最終用戶產生了許多實際影響。部分進口零件和成品關稅的提高，促使原始設備製造商 (OEM) 重新評估其籌資策略，重新審查供應商契約，並儘可能在本地採購關鍵子系統。這些調整促使在地採購計畫更加重視總到岸成本、供應鏈韌性以及合約柔軟性，以應對關稅波動和海關清關時間的變化。

將應用主導的需求、最終用戶優先事項和技術平台差異轉化為產品和採購團隊可以利用的細分洞察

從應用角度來看，產品需求差異顯著。牙科手術設備必須優先考慮面積小巧、操作簡單以及在重複性低能量成像中實現高劑量效率。而一般外科手術則需要靈活的定位和快速的影像擷取，以支援術中決策。整形外科應用尤其需要高解析度影像和透視連續性，以支持關節重建、脊椎和創傷手術。即使在脊椎手術中，由於解剖結構和手術入路的不同，頸椎和腰椎手術也需要不同的影像策略。疼痛管理應用則優先考慮精準的針頭導引、低劑量透視以及易於定位，以適應重複性的門診手術。

分析區域採購趨勢、監管差異和服務需求，以了解影響全球醫療保健市場設備選擇和採用的因素

區域趨勢對低功耗移動式C型臂的需求和部署策略均有顯著影響。在美洲，私人醫院的投資週期以及門診中心的擴張往往會影響採購決策，這表明市場對整合服務產品和融資模式有著濃厚的興趣，這些產品和服務能夠支援快速部署，同時又不影響全生命週期支援。同時，歐洲、中東和非洲地區的情況則更為複雜，監管協調、不同的報銷模式以及醫院基礎設施能力的差異迫使供應商提供客製化的配置和針對特定區域的培訓項目，以確保產品能夠在不同的市場順利部署。

分析競爭對手如何結合技術差異化、服務產品和通路夥伴關係，以確保長期臨床應用和生命週期價值。

低功耗移動式C臂機的競爭動態日益受到產品創新和服務能力的雙重驅動。一些製造商主要依靠技術差異化競爭，透過強調檢測器性能、先進的影像處理技術和符合人體工學的設計來吸引臨床要求較高的專科醫生。另一些製造商則專注於整合服務模式，將預防性保養、軟體更新、培訓和備件等服務打包到可預測的營運合約中，從而減輕醫院採購部門的行政負擔。

為供應商和買家製定優先且可行的策略，以增強設備在整個生命週期中的韌性、臨床整合和服務主導的差異化優勢。

供應商應優先投資於可互通軟體和遠距離診斷，以減少停機時間和提升產品全生命週期價值，從而實現差異化競爭。製造商與其僅在初始價格上競爭，不如建立模組化升級路徑和清晰的服務等級協定 (SLA)，這樣可以使產品藍圖與醫院預算保持一致，並幫助臨床團隊規劃逐步的功能增強。此外，為關鍵零件建立檢驗的近岸外包或雙重採購安排，有助於在維持品管的同時，減輕貿易和關稅波動對生產計畫的影響。

我們將解釋支撐這項分析和策略建議的多源調查方法、專家檢驗過程和數據三角測量技術。

我們的研究途徑包括對臨床負責人、生物醫學工程經理、採購專業人員和設備服務專家進行初步訪談，以全面觀點使用模式、維護負擔和採購重點。除了這些定性見解外，我們還對成像平台進行了技術評估，對檢測器技術進行了比較分析，並分析了監管要求和相關文件，以確保充分體現臨床視角和合規要求。

總結臨床需求、設備功能和策略採購選擇如何相互作用，從而決定移動式C臂的長期臨床和營運價值。

微創手術的臨床需求不斷成長，加之檢測器技術和設備人體工學的進步，使得低功耗移動式C臂的實際應用範圍不斷擴大，涵蓋了更廣泛的醫療環境。因此，採購決策也從簡單的商品採購演變為需要臨床、技術和財務等各相關人員通力合作的策略投資。能夠提供互操作系統、完善的服務網路和清晰升級路徑的供應商，將在競爭激烈的採購過程中脫穎而出。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 低功耗移動C臂市場（依技術分類）

  • 平板檢測器
  • 影像增強器

9. 低功耗移動C臂市場（按應用分類）

  • 牙科
  • 一般外科
  • 整形外科
    • 關節重建
    • 脊椎手術
      • 頸椎
      • 腰部
    • 創傷外科
  • 疼痛管理

第10章 低功耗行動C臂市場（依最終用戶分類）

  • 門診手術中心
  • 牙醫診所
  • 醫院
    • 當地醫療機構
    • 三級醫療
  • 整形外科診所
  • 疼痛管理診所

第11章 低功率移動式C臂市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 低功耗行動C臂市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國低功耗移動式C臂市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

14. 美國低功耗行動C臂市場

第15章 中國的低功耗行動C臂市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Analogic Corporation
  • Canon Medical Systems Corporation
  • DMS Group
  • DRGEM Co., Ltd.
  • General Electric Company
  • Hologic, Inc.
  • Koninklijke Philips NV
  • OrthoScan, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • SternMed GmbH
  • Ziehm Imaging GmbH
Product Code: MRR-4F7A6D4FF368

The Low Power Mobile C-arm Market was valued at USD 1.19 billion in 2025 and is projected to grow to USD 1.28 billion in 2026, with a CAGR of 7.42%, reaching USD 1.97 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.19 billion
Estimated Year [2026] USD 1.28 billion
Forecast Year [2032] USD 1.97 billion
CAGR (%) 7.42%

Introducing the clinical context, procurement priorities, and technological expectations that are reshaping adoption of low power mobile C-arms across modern care environments

This executive summary frames the evolving role of low power mobile C-arms within contemporary clinical workflows, highlighting how technological refinements and changing care delivery models are reshaping procurement and usage patterns. The discussion opens with clinical drivers: minimally invasive procedures, point-of-care interventions, and the increasing volume of procedures taking place outside traditional operating rooms are accentuating demand for compact, lower-dose imaging solutions. In parallel, clinicians are seeking systems that strike a balance between image quality and maneuverability to support rapid turnover, shorter procedure times, and enhanced patient throughput.

From an operational perspective, hospital imaging teams and ambulatory surgery centers are prioritizing devices that reduce total cost of ownership through simplified maintenance, modular serviceability, and robust remote diagnostics. As a result, manufacturers are directing design efforts toward streamlined user interfaces, intuitive positioning aids, and integrated dose-management features. These advances dovetail with regulatory emphasis on patient safety and radiation stewardship, prompting buyers to weigh compliance capabilities as heavily as image performance.

Taken together, these clinical and operational dynamics are creating new expectations for mobile C-arms: devices must be agile enough for point-of-care settings, mature enough to meet surgical imaging demands, and economically sustainable across diverse care environments. The following sections analyze the strategic inflection points, regulatory and trade-related pressures, customer segmentation nuances, and regional considerations that decision-makers should factor into procurement and deployment strategies.

Explaining the technological, clinical workflow, and service model shifts that are fundamentally altering purchasing criteria and competitive positioning for mobile C-arm suppliers

A confluence of technological improvements and care-delivery shifts has altered the competitive landscape for mobile C-arms. Flat panel detectors and advanced image processing algorithms have progressively closed the gap between portable and fixed imaging systems, enabling clinicians to perform increasingly complex interventions with devices that occupy a fraction of floor space and power budget. At the same time, advances in battery systems and lightweight materials have made intra-procedural repositioning quicker and less disruptive, unlocking new workflows in ambulatory, bedside, and hybrid settings.

Concurrently, clinical practice is moving toward minimally invasive and image-guided procedures across orthopedics, spinal care, and pain management, which places a premium on real-time imaging fidelity and radiation optimization. This trend is motivating manufacturers to embed features such as dose-monitoring dashboards and automated exposure controls, thereby aligning product roadmaps with clinician priorities for safety and efficiency. As a result, purchasing committees are increasingly cross-functional, involving surgeons, radiology technologists, biomedical engineering teams, and finance partners to evaluate devices against a broader set of clinical and operational criteria.

Finally, digital transformation is injecting new expectations around interoperability, remote serviceability, and data analytics. Stakeholders now expect imaging equipment to integrate seamlessly with hospital information systems, support image export to PACS and cloud repositories, and enable remote diagnostics to minimize downtime. Taken together, these transformative shifts require suppliers to offer not only hardware improvements but also software-enabled service models, training programs, and lifecycle partnerships that support long-term clinical adoption and institutional objectives.

Evaluating how new United States tariff measures are reshaping sourcing choices, total landed costs, and procurement risk management for mobile C-arm stakeholders

Recent tariff changes have introduced a range of practical consequences for manufacturers, distributors, and end users of imaging equipment. Increased duties on certain imported components and finished devices have prompted original equipment manufacturers to revisit sourcing strategies, re-evaluate supplier contracts, and pursue localization for critical subsystems where feasible. These adjustments have, in turn, impacted procurement planning by creating greater emphasis on total landed cost, supply chain resilience, and contractual flexibility to accommodate variable duties and customs processing timelines.

In response, some suppliers have shifted to dual-sourcing models and nearshoring arrangements to mitigate exposure to trade policy volatility. These moves often require short lead-time suppliers with validated quality systems and regulatory-compliant manufacturing processes, and they may necessitate additional capital investment to qualify new production partners. For health systems and device purchasers, the consequence is that procurement cycles increasingly factor in supplier geographic diversity and contractual protections such as long-term pricing clauses and expedited replacement guarantees.

Moreover, tariff-driven cost pressures are accelerating discussions about value-based procurement, extended warranties, and service bundling as mechanisms to control lifecycle costs. Hospitals and ambulatory centers are scrutinizing total ownership considerations and favoring suppliers that can demonstrate dependable spare parts availability, transparent cost structures, and strong after-sales support. Collectively, these dynamics are encouraging a more strategic, partnership-oriented procurement posture that balances cost, continuity of care, and rapid access to critical imaging assets.

Translating application-driven requirements, end user priorities, and technology platform differences into actionable segmentation insights for product and procurement teams

When viewed through application lenses, product requirements diverge notably. Devices intended for dental procedures must prioritize compact footprints, simplified controls, and dose efficiency for repetitive, low-energy imaging, whereas general surgery applications require flexible positioning and rapid image acquisition to support intraoperative decision-making. Orthopedic use cases drive distinct demands for high-resolution imaging and fluoroscopic continuity to support joint replacement, spinal surgery, and trauma surgery; within spinal surgery, differentiated imaging strategies are required for cervical procedures versus lumbar interventions due to anatomical and operative access considerations. Pain management applications prioritize precise needle guidance, low-dose fluoroscopy, and ease of repositioning for repeated outpatient procedures.

End user contexts impose further nuance on procurement and deployment. Ambulatory surgery centers and dental clinics favor systems that minimize footprint, require limited infrastructure changes, and offer straightforward service contracts. Hospitals, which can be community-level hospitals or tertiary care centers, evaluate devices against broader interoperability, high-utilization durability, and advanced functionality for complex procedures. Orthopedic clinics and dedicated pain management clinics tend to emphasize specialized imaging features and service responsiveness that support high procedure volumes and rapid patient throughput.

On the technology front, the choice between flat panel detector systems and image intensifier architectures remains a defining performance tradeoff. Flat panel detectors deliver superior image uniformity, enhanced post-processing capabilities, and often lower maintenance profiles, while image intensifiers can offer cost advantages and proven reliability in certain clinical workflows. Suppliers and purchasers alike must align technology selection with procedural mix, training capacity, and anticipated lifecycle service needs to ensure clinical efficacy and operational sustainability.

Unpacking regional procurement dynamics, regulatory nuances, and service requirements that influence device selection and implementation across global healthcare markets

Regional dynamics exert a strong influence on both demand and deployment strategies for low power mobile C-arms. In the Americas, purchasing decisions are frequently shaped by a combination of private hospital investment cycles and ambulatory center expansion; this region shows strong interest in integrated service offerings and financing models that support rapid acquisition without compromising lifecycle support. Moving from there, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization, variable reimbursement models, and differing hospital infrastructure capabilities require suppliers to offer tailored configurations and localized training programs to achieve adoption across disparate markets.

Asia-Pacific is characterized by rapid capacity expansion in both public and private healthcare sectors, paired with an appetite for scalable, cost-efficient imaging solutions that can be deployed across a wide range of clinical settings. Within each region, local regulatory pathways and certification requirements influence time-to-deployment and the scope of clinical validation needed for devices, which in turn affect supplier go-to-market sequencing and resource allocation. Furthermore, cross-border service considerations such as spare parts logistics, in-region technical training, and remote support capabilities shape long-term service commitments and influence buyer preferences for manufacturers with established regional footprints.

Taken together, these regional considerations suggest that suppliers and purchasers should adopt differentiated strategies that reflect local reimbursement environments, regulatory regimes, and the maturity of surgical and imaging infrastructure to maximize clinical impact and operational efficiency.

Profiling how competitors are combining technological differentiation, service delivery, and channel partnerships to secure long-term clinical adoption and lifecycle value

Competitive dynamics in the low power mobile C-arm sector are increasingly driven by the combination of product innovation and service capability. Some manufacturers are competing primarily on technological differentiation, emphasizing detector performance, advanced image processing, and ergonomic design to appeal to clinically demanding specialties. Others are leaning into integrated service models that bundle preventative maintenance, software updates, training, and spare parts into predictable operating contracts that reduce administrative burden for hospital procurement teams.

Strategic partnerships and channel diversification are common approaches to broaden geographic reach while managing capital intensity. Distributors and independent service organizations play a material role in enabling manufacturers to extend localized support, particularly in regions where direct presence is limited. For buyers, the presence of a robust service network often outweighs marginal differences in technical specifications, since uptime and rapid access to parts and technicians directly affect clinical throughput and patient care continuity.

Finally, product portfolios are being shaped by lifecycle management strategies that include modular upgrades, software-driven feature enhancements, and cross-compatible accessories to extend device utility. These approaches enable suppliers to maintain longer customer relationships, create upgrade pathways that align with hospital budgeting cycles, and provide demonstrable value through incremental performance improvements rather than frequent hardware replacements.

Prioritized, implementable strategies for suppliers and buyers to enhance device resilience, clinical integration, and service-driven differentiation across the lifecycle

Suppliers should prioritize investment in interoperable software and remote diagnostics to reduce downtime and differentiate on total lifecycle value rather than solely on upfront price. By developing modular upgrade paths and clear service-level agreements, manufacturers can align product roadmaps with institutional budgeting horizons and help clinical teams plan for incremental capability additions. In addition, establishing validated nearshoring or dual-sourcing arrangements for critical components can insulate production timelines from trade and tariff volatility while preserving quality control.

Healthcare providers should adopt cross-functional evaluation teams that include clinical, biomedical engineering, and supply chain stakeholders to assess devices against a balanced set of criteria: procedural fit, training requirements, service responsiveness, and long-term maintainability. Procuring entities can also negotiate outcome-oriented service contracts and prioritized spare parts agreements to ensure continuity of care. For distributors and channel partners, building technical training programs and localized maintenance hubs will strengthen value propositions in regionally diverse markets and support faster deployment cycles.

Across the ecosystem, stakeholders should also invest in clinician training and standardized protocols to ensure consistent image acquisition practices and radiation safety. These investments enhance clinical confidence, reduce variation in outcomes, and support broader adoption. By executing on these prioritized actions, organizations can improve operational resilience, accelerate technology adoption where clinically warranted, and create durable competitive advantages rooted in service excellence and clinical alignment.

Explaining the multi-source research methodology, expert validation processes, and data triangulation techniques that underpinned the analysis and strategic recommendations

The research approach combined primary interviews with clinical leaders, biomedical engineering managers, procurement professionals, and device service specialists to capture a holistic perspective on usage patterns, maintenance burdens, and purchasing priorities. These qualitative inputs were complemented by technical assessments of imaging platforms, comparative reviews of detector technologies, and analysis of regulatory requirements and documentation to ensure clinical and compliance considerations were thoroughly represented.

To validate findings, multiple data streams were triangulated: interview-derived insights were cross-checked against device specification sheets, service literature, and clinical procedure protocols. Where applicable, anonymized operational metrics such as utilization patterns, maintenance turnaround times, and downtime reports were reviewed to corroborate practitioner feedback. Regional regulatory reviews and trade-policy analyses were also incorporated to contextualize supply chain and procurement implications.

Finally, iterative expert reviews with independent clinicians and technical advisors were conducted to refine interpretations and ensure the practical applicability of recommendations. This layered methodology supports robust, decision-relevant insights while aligning research outputs with the informational needs of clinical leaders, procurement teams, and product strategists.

Summarizing how clinical imperatives, device capabilities, and strategic procurement choices intersect to determine the long-term clinical and operational value of mobile C-arms

Emerging clinical demands for minimally invasive procedures, combined with improvements in detector technology and device ergonomics, are expanding the practical applications for low power mobile C-arms across a wider array of care settings. Procurement decisions are therefore evolving from commodity purchases into strategic investments that require alignment across clinical, technical, and financial stakeholders. Suppliers that respond with interoperable systems, robust service networks, and clear upgrade pathways will be advantaged in competitive procurement processes.

Trade policy shifts and regional regulatory nuances add complexity to sourcing and deployment, underscoring the need for flexible supply chains and service models that can adapt to variable duty structures and localized certification requirements. Ultimately, success will hinge on partnerships that balance device capability with predictable lifecycle support, clinician training, and data-enabled performance management. By prioritizing these elements, decision-makers can ensure that imaging investments deliver sustained clinical value, operational resilience, and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Low Power Mobile C-arm Market, by Technology

  • 8.1. Flat Panel Detector
  • 8.2. Image Intensifier

9. Low Power Mobile C-arm Market, by Application

  • 9.1. Dental
  • 9.2. General Surgery
  • 9.3. Orthopedic
    • 9.3.1. Joint Replacement
    • 9.3.2. Spinal Surgery
      • 9.3.2.1. Cervical
      • 9.3.2.2. Lumbar
    • 9.3.3. Trauma Surgery
  • 9.4. Pain Management

10. Low Power Mobile C-arm Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Dental Clinics
  • 10.3. Hospitals
    • 10.3.1. Community
    • 10.3.2. Tertiary Care
  • 10.4. Orthopedic Clinics
  • 10.5. Pain Management Clinics

11. Low Power Mobile C-arm Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Low Power Mobile C-arm Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Low Power Mobile C-arm Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Low Power Mobile C-arm Market

15. China Low Power Mobile C-arm Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Analogic Corporation
  • 16.6. Canon Medical Systems Corporation
  • 16.7. DMS Group
  • 16.8. DRGEM Co., Ltd.
  • 16.9. General Electric Company
  • 16.10. Hologic, Inc.
  • 16.11. Koninklijke Philips N.V.
  • 16.12. OrthoScan, Inc.
  • 16.13. Shimadzu Corporation
  • 16.14. Siemens Healthineers AG
  • 16.15. SternMed GmbH
  • 16.16. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LOW POWER MOBILE C-ARM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LOW POWER MOBILE C-ARM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY FLAT PANEL DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY FLAT PANEL DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY CERVICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY CERVICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY CERVICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY LUMBAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY LUMBAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY LUMBAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TRAUMA SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TRAUMA SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COMMUNITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COMMUNITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COMMUNITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 131. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 152. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 159. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)